MedTrace Logo

Lemborexant Treatment of Insomnia Linked to Epilepsy

NCT06262594 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-02-13

No results posted yet for this study

Summary

The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.

Conditions

Interventions

DRUG

Lemborexant

Drug is administered

DRUG

Placebo

Drug is administered

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-29
Primary Completion
2026-04-18
Completion
2027-04-18
FDA Drug
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06262594 on ClinicalTrials.gov